LABU vs. XTAP
Compare and contrast key facts about Direxion Daily S&P Biotech Bull 3x Shares (LABU) and Innovator U.S. Equity Accelerated Plus ETF (XTAP).
LABU and XTAP are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. LABU is a passively managed fund by Direxion that tracks the performance of the S&P Biotechnology Select Industry Index (300%). It was launched on May 28, 2015. XTAP is an actively managed fund by Innovator. It was launched on Apr 1, 2021.
Performance
LABU vs. XTAP - Performance Comparison
Loading graphics...
LABU vs. XTAP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
LABU Direxion Daily S&P Biotech Bull 3x Shares | 4.20% | 79.17% | -26.02% | -13.41% | -80.36% | -55.63% |
XTAP Innovator U.S. Equity Accelerated Plus ETF | 1.66% | 17.58% | 14.26% | 23.46% | -14.68% | 11.87% |
Returns By Period
In the year-to-date period, LABU achieves a 4.20% return, which is significantly higher than XTAP's 1.66% return.
LABU
- 1D
- 22.31%
- 1M
- -3.83%
- YTD
- 4.20%
- 6M
- 78.34%
- 1Y
- 175.22%
- 3Y*
- 19.86%
- 5Y*
- -36.38%
- 10Y*
- -11.81%
XTAP
- 1D
- 0.08%
- 1M
- 0.65%
- YTD
- 1.66%
- 6M
- 4.34%
- 1Y
- 16.29%
- 3Y*
- 16.22%
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LABU vs. XTAP - Expense Ratio Comparison
LABU has a 1.12% expense ratio, which is higher than XTAP's 0.79% expense ratio.
Return for Risk
LABU vs. XTAP — Risk / Return Rank
LABU
XTAP
LABU vs. XTAP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and Innovator U.S. Equity Accelerated Plus ETF (XTAP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LABU | XTAP | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.04 | 1.14 | +0.90 |
Sortino ratioReturn per unit of downside risk | 2.48 | 1.76 | +0.72 |
Omega ratioGain probability vs. loss probability | 1.31 | 1.44 | -0.13 |
Calmar ratioReturn relative to maximum drawdown | 3.74 | 1.43 | +2.31 |
Martin ratioReturn relative to average drawdown | 11.90 | 9.78 | +2.12 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| LABU | XTAP | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.04 | 1.14 | +0.90 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.38 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.12 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.24 | 0.69 | -0.93 |
Correlation
The correlation between LABU and XTAP is 0.52, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
LABU vs. XTAP - Dividend Comparison
LABU's dividend yield for the trailing twelve months is around 0.74%, while XTAP has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LABU Direxion Daily S&P Biotech Bull 3x Shares | 0.74% | 0.84% | 0.35% | 0.35% | 0.00% | 0.00% | 0.00% | 0.28% | 0.64% | 0.17% |
XTAP Innovator U.S. Equity Accelerated Plus ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
LABU vs. XTAP - Drawdown Comparison
The maximum LABU drawdown since its inception was -99.18%, which is greater than XTAP's maximum drawdown of -22.13%. Use the drawdown chart below to compare losses from any high point for LABU and XTAP.
Loading graphics...
Drawdown Indicators
| LABU | XTAP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.18% | -22.13% | -77.05% |
Max Drawdown (1Y)Largest decline over 1 year | -36.66% | -11.83% | -24.83% |
Max Drawdown (5Y)Largest decline over 5 years | -97.75% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -98.96% | — | — |
Current DrawdownCurrent decline from peak | -96.33% | 0.00% | -96.33% |
Average DrawdownAverage peak-to-trough decline | -81.45% | -3.57% | -77.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.01% | 1.73% | +10.28% |
Volatility
LABU vs. XTAP - Volatility Comparison
Direxion Daily S&P Biotech Bull 3x Shares (LABU) has a higher volatility of 33.99% compared to Innovator U.S. Equity Accelerated Plus ETF (XTAP) at 0.77%. This indicates that LABU's price experiences larger fluctuations and is considered to be riskier than XTAP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| LABU | XTAP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 33.99% | 0.77% | +33.22% |
Volatility (6M)Calculated over the trailing 6-month period | 56.88% | 2.52% | +54.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 87.36% | 14.33% | +73.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 95.74% | 14.60% | +81.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 95.91% | 14.60% | +81.31% |